# 2-arm Parallel Group Study of Fixed Combination of CHF 5993 vs Ultibro® in COPD Patients

> **NCT02579850** · PHASE3 · COMPLETED · sponsor: **Chiesi Farmaceutici S.p.A.** · enrollment: 1532 (actual)

## Conditions studied

- Chronic Obstructive Pulmonary Disease (COPD)

## Interventions

- **DRUG:** CHF 5993 + Ultibro matched placebo
- **DRUG:** Ultibro + CHF 5993 matched placebo
- **PROCEDURE:** Central spirometry
- **OTHER:** COPD assessment test
- **PROCEDURE:** Local laboratory Assessments
- **OTHER:** Saint George's Respiratory Questionnaire
- **OTHER:** EXACT-pro questionnaire

## Key facts

- **NCT ID:** NCT02579850
- **Lead sponsor:** Chiesi Farmaceutici S.p.A.
- **Sponsor class:** INDUSTRY
- **Phase:** PHASE3
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 2015-05-29
- **Primary completion:** 2017-07-10
- **Final completion:** 2017-07-10
- **Target enrollment:** 1532 (ACTUAL)
- **Last updated:** 2021-10-29


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT02579850

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT02579850, "2-arm Parallel Group Study of Fixed Combination of CHF 5993 vs Ultibro® in COPD Patients". Retrieved via AI Analytics 2026-06-02 from https://api.ai-analytics.org/clinical/NCT02579850. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*